New Alzheimer s drug shines light on need for assessments to head off a tsunami of cognitive afflictions medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Interdisciplinary panel offers solutions to improve recruitment for Alzheimer s clinical trials miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Unless cures are found, Alzheimer's dementia is projected to affect nearly 13 million Americans by 2050-;overwhelming families, caregivers and our healthcare system. Yet only one new therapeutic, aducanumab, has come to market in the past 20 years, and therapeutic progress remains hampered for several reasons: recruiting study participants in clinical trials for Alzheimer's is more challenging than other disease areas, the trials take longer to complete and they are more costly.
Few Older Adults Knowledgeable About Aducanumab for Alzheimer Disease empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.